Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Zostavax in Adults 70+
NCT02624375Phase 4Completed
- Sponsor
- University of Washington
- Start
- Feb 2016
- Primary completion
- Nov 2019
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of zoster vaccine, live in herpes zoster (HZ), sponsored by University of Washington. Started Feb 2016; status: completed.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02624375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624375.